相关实验视频
Updated: Jun 18, 2026

19:32
Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
28.4K
项目启动:一个临床可行性试验,公平获得早期神经发育疗法
Jessica Trenkle1, Alison Liddle2, Lynn Boswell1
1Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
Journal of clinical medicine
|January 8, 2025
概括
在NICU/CICU出院后,有公共保险的婴儿可以进行家庭物理治疗 (PT). 早期PT改善了运动结果,强调需要解决这些脆弱婴儿的早期干预 (EI) 进入障碍.
科学领域:
- 儿科 儿科 儿科
- 新生儿护理 新生儿护理
- 物理疗法物理治疗
背景情况:
- 早期干预 (EI) 计划对婴儿发育至关重要,但许多符合条件的婴儿面临服务启动延迟或被排除在外.
- 在EI入学方面存在差异,持有公共保险的婴儿的参与率较低.
- 新生儿或心脏重症监护室 (NICU/CICU) 的毕业生,特别是那些有公共保险的人,可能会受益于及时的出院后支持.
研究的目的:
- 评估在NICU/CICU出院后,对有公共保险的婴儿立即启动家庭物理治疗 (PT) 的可行性.
- 为了比较在家中接受PT和接受标准护理的婴儿之间的早期运动结果.
- 确定影响早期干预 (EI) 进入这一群体的障碍.
主要方法:
- 一项试点研究涉及从NICU/CICU出院的婴儿,有公共保险,有资格获得伊利诺伊州EI服务.
- 干预组 (n=46) 接受每周一次家庭培训,直到3至4个月的校正年龄 (CA);对照组 (n=14) 接受标准护理.
- 婴儿在出院时接受了婴儿运动性能测试 (TIMP),并跟踪了3-4个月的CA,PT和EI启动率.
主要成果:
- 在干预组中,78%的患者在CA 3-4个月前至少接受了一次PT课程,证明了可行性.
- 整个队列中只有13%的人接受了任何EI治疗,这表明了显著的获取差距.
- 接受8-10个PT会话的婴儿在TIMPZ分数 (>0.5SD) 中表现出更大的改善.
结论:
- 快速的家庭PT是公共保险的城市婴儿的可行方法,可能优化神经可塑性变化.
- 该研究突出了早期干预 (EI) 获得公共保险的婴儿的重大障碍.
- 解决已识别的障碍对于改善对有风险的婴儿提供EI服务至关重要.
更多相关视频
08:42A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
8.2K
11:50Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
26.2K
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...